4 Smallcap Promoter Backed Fast Revenue Growth and Revenue CAGR Stocks to Watch for Future Multibagger Potential: Emmvee, Vijaya Diagnostic, Century Plyboards and TRIL
- November 11, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
Emmvee Rs 264.48. Vijaya Diagnostic Rs 1,478.30. Century Plyboards Rs 653.95. TRIL Rs 310.10. Market caps from Rs 9,221 crore to Rs 20,759 crore. Data as of 10 Nov 2026.
Quick Answer
Emmvee, Vijaya Diagnostic, Century Plyboards and TRIL are the 4 picks in this promoter backed fast revenue growth and revenue CAGR stocks watchlist, with market caps between Rs 9,221 crore and Rs 20,759 crore. Emmvee stands out for the highest return on equity at 32.31%, while Vijaya Diagnostic offers the fastest profit growth, 11.81% a year since FY22. PE ratios run from 14.63 to 82.01, so compare each one with its industry PE before investing. All figures are as of 10 November 2026.
Promoter backed fast revenue growth and revenue CAGR stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Emmvee, Vijaya Diagnostic, Century Plyboards and TRIL meet that test, with market caps from Rs 9,221 crore to Rs 20,759 crore and Emmvee offering the highest return on equity at 32.31%. Each of these companies has a market capitalisation below Rs 30,000 crore and a promoter holding of at least 50 per cent, FY26 revenue growth of at least 15 per cent and a four year revenue CAGR of at least 15 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.
This list covers companies with a market capitalisation below Rs 30,000 crore and a promoter holding of at least 50 per cent, FY26 revenue growth of at least 15 per cent and a four year revenue CAGR of at least 15 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap below Rs 30,000 crore. Investors screening promoter backed fast revenue growth and revenue CAGR stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 10 November 2026 and are drawn from NSE and BSE data and company filings.
Click Here – Get Free Investment Predictions
What Are Promoter Backed Fast Revenue Growth and Revenue CAGR Stocks and Why Do They Attract Multibagger Interest?
Promoter backed fast revenue growth and revenue CAGR stocks are shares of smaller companies in which the promoters own at least half of the business, sales grew by fifteen per cent or more in FY26 and sales have compounded at fifteen per cent or more a year over four years. The four here cover solar modules, diagnostic centres, plywood and transformers.
Owners with a large stake have their own wealth tied to the company, and sales that grew fast in FY26 on top of a four year compounding record show demand that keeps expanding. Within promoter backed fast revenue growth and revenue CAGR stocks, the four companies show rising profit. For promoter backed fast revenue growth and revenue CAGR stocks, both FY26 and the latest quarter showed growth. Whichever way you read promoter backed fast revenue growth and revenue CAGR stocks, the common thread is rising profit backed by complete financial data. For promoter backed fast revenue growth and revenue CAGR stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of promoter backed fast revenue growth and revenue CAGR stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for promoter backed fast revenue growth and revenue CAGR stocks before you decide.
Promoter Backed Fast Revenue Growth and Revenue CAGR Stocks at a Glance: Price, Market Cap, PE and ROE
Prices are closing prices as of 10 November 2026. Emmvee combines the lowest PE of the group, 14.63, with the highest return on equity, 32.31%.
| Stock | CMP (Rs) | Market Cap (Rs Cr) | PE | Industry PE | ROE | Debt to Equity | 52-Week Range (Rs) |
|---|---|---|---|---|---|---|---|
| Emmvee Photovoltaic Power | 264.48 | 20,759 | 14.63 | 45.89 | 32.31% | 0.25 | 171.51 to 371.55 |
| Vijaya Diagnostic Centre | 1,478.30 | 15,373 | 82.01 | 60.75 | 18.07% | 0.44 | 848.00 to 1,593.60 |
| Century Plyboards India | 653.95 | 14,523 | 48.63 | 36.42 | 10.07% | 0.68 | 618.50 to 859.00 |
| Transformers and Rectifiers India | 310.10 | 9,221 | 29.45 | 45.89 | 18.42% | 0.35 | 224.05 to 492.30 |
Emmvee: Revenue Up 116.22% in FY26
Emmvee Photovoltaic Power makes solar cells and solar modules at its plants in Karnataka. It reported FY26 revenue of Rs 5,103.39 crore, up 116.22% year on year, and net profit of Rs 1,081.55 crore, up 193.10%. Revenue has compounded at 73.18% a year since FY22. Operating margin was 35.40% in FY26. The debt-to-equity ratio is 0.25.
In the September 2026 quarter, revenue rose 37.37% to Rs 1,578.90 crore and net profit grew 60.62% to Rs 382.05 crore. Domestic institutions raised their holding from 0.00% in July 2025 to 9.80% in June 2026. The stock trades at a PE of 14.63 against an industry PE of 45.89, below the sector average, with a return on equity of 32.31%.
Vijaya Diagnostic: Quarterly Profit Up 37.60%
Vijaya Diagnostic Centre runs diagnostic centres offering pathology and radiology services, with a strong base in South India. It reported FY26 revenue of Rs 835 crore, up 19.34% year on year, and net profit of Rs 172.98 crore, up 20.30%. Net profit has compounded at 11.81% a year since FY22, while revenue has grown 15.13% a year. Operating margin was 43.94% in FY26. The debt-to-equity ratio is 0.44.
The stock trades at a PE of 82.01 against an industry PE of 60.75, with a return on equity of 18.07%. In the June 2026 quarter, revenue rose 22.76% to Rs 239.51 crore and net profit grew 37.60% to Rs 53.10 crore. The share price has gained 137.56% over five years and 36.29% over the past year. Domestic institutions raised their holding from 25.34% in September 2025 to 32.50% in September 2026.
Century Plyboards: Quarterly Profit Up 57.38%
Century Plyboards India is a leading maker of plywood, laminates, MDF and particle boards and sells under the Century brand. It reported FY26 revenue of Rs 5,407.42 crore, up 19.16% year on year, and net profit of Rs 268.33 crore, up 44.20%. Revenue has compounded at 15.39% a year since FY22. Operating margin was 12.10% in FY26.
In the June 2026 quarter, revenue rose 33.50% to Rs 1,563.55 crore and net profit grew 57.38% to Rs 83.30 crore. Domestic institutions raised their holding from 18.14% in September 2025 to 19.49% in September 2026. The stock trades at a PE of 48.63 against an industry PE of 36.42.
TRIL: Revenue Up 25.28% in FY26
Transformers and Rectifiers India makes power and distribution transformers and reactors for utilities and industry. It reported FY26 revenue of Rs 2,569.65 crore, up 25.28% year on year, and net profit of Rs 272.17 crore, up 25.75%. Revenue has compounded at 21.70% a year since FY22. Operating margin was 17.70% in FY26. The debt-to-equity ratio is 0.35.
The stock trades at a PE of 29.45 against an industry PE of 45.89, below the sector average, with a return on equity of 18.42%. In the September 2026 quarter, revenue rose 56.59% to Rs 742.16 crore and net profit grew 117.88% to Rs 81.38 crore. The share price has gained 2088.31% over five years. Promoters hold 64.36%, which keeps ownership stable.
Promoter Backed Fast Revenue Growth and Revenue CAGR Stocks: Financial Comparison on Growth and Margins
The table compares scale and growth across these promoter backed fast revenue growth and revenue CAGR stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.
| Stock | Revenue (Rs Cr) | Net Profit (Rs Cr) | Revenue Growth (YoY) | 4-Year Revenue CAGR | Latest Quarter Revenue Growth | Operating Margin (Latest Quarter) |
|---|---|---|---|---|---|---|
| Emmvee | 5,103.39 | 1,081.55 | 116.22% | 73.18% | 37.37% | 35.49% |
| Vijaya Diagnostic | 835 | 172.98 | 19.34% | 15.13% | 22.76% | 46.35% |
| Century Plyboards | 5,407.42 | 268.33 | 19.16% | 15.39% | 33.50% | 12.81% |
| TRIL | 2,569.65 | 272.17 | 25.28% | 21.70% | 56.59% | 17.78% |
Institutional Holding in Emmvee, Vijaya Diagnostic, Century Plyboards and TRIL
Institutional holding shows who is backing these promoter backed fast revenue growth and revenue CAGR stocks alongside the promoter. The table uses the latest reported quarter for each. Vijaya Diagnostic has the deepest institutional backing, with FII and DII together holding 43.16% as of September 2026. Domestic institutions increased their holding over the past year in Emmvee (from 0.00% to 9.80%), Vijaya Diagnostic (from 25.34% to 32.50%) and Century Plyboards (from 18.14% to 19.49%). To see how this group fits the wider market, many investors compare it with the Nifty Smallcap 100.
| Stock | Promoter | FII | DII | Public | Quarter |
|---|---|---|---|---|---|
| Emmvee | 80.03% | 2.92% | 9.80% | 7.25% | June 2026 |
| Vijaya Diagnostic | 52.46% | 10.66% | 32.50% | 4.38% | September 2026 |
| Century Plyboards | 71.83% | 3.61% | 19.49% | 5.08% | September 2026 |
| TRIL | 64.36% | 6.99% | 1.19% | 27.46% | September 2026 |
Risks to Weigh in Promoter Backed Fast Revenue Growth and Revenue CAGR Stocks
Being careful with promoter backed fast revenue growth and revenue CAGR stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:
- Past growth may not repeat.
- Share prices can move sharply in either direction.
- Valuation: Vijaya Diagnostic trades at a PE of 82.01 against an industry PE of 60.75, so earnings need to keep growing to support the price.
- Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.
How to Choose Between Promoter Backed Fast Revenue Growth and Revenue CAGR Stocks
Picking from promoter backed fast revenue growth and revenue CAGR stocks comes down to four checks, applied in order.
- Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
- Compare each PE with the industry PE (36.42 to 60.75) and ask whether the growth rate justifies any gap.
- Track net profit growth, the operating margin and the return on equity in every quarterly result.
- Stagger entries across quarters and review institutional holding every reporting season.
Download the Univest iOS App or Univest Android App to track Emmvee, Vijaya Diagnostic, Century Plyboards and TRIL live prices.
Conclusion
Among promoter backed fast revenue growth and revenue CAGR stocks, Emmvee stands out for the highest return on equity at 32.31%, Vijaya Diagnostic for the fastest profit growth, 11.81% a year since FY22, Century Plyboards for 19.16% revenue growth in FY26 and TRIL for the biggest five-year price gain at 2088.31%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing promoter backed fast revenue growth and revenue CAGR stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions on Promoter Backed Fast Revenue Growth and Revenue CAGR Stocks to Watch
Which are the best promoter backed fast revenue growth and revenue CAGR stocks to watch for multibagger potential?
Ans. Emmvee, Vijaya Diagnostic, Century Plyboards and TRIL are the 4 names this list highlights, with market caps of Rs 20,759 crore, Rs 15,373 crore, Rs 14,523 crore and Rs 9,221 crore respectively. Emmvee is notable for the highest return on equity at 32.31%. Vijaya Diagnostic stands out for the fastest profit growth, 11.81% a year since FY22. Century Plyboards offers 19.16% revenue growth in FY26. TRIL brings the biggest five-year price gain at 2088.31%. These are watchlist names for promoter backed fast revenue growth and revenue CAGR stocks, not recommendations, so match each one to your own risk profile and time horizon.
Is Emmvee a good stock for long-term investors?
Ans. Emmvee has a return on equity of 32.31%, a PE of 14.63 against an industry PE of 45.89 and a market cap of Rs 20,759 crore. FY26 revenue rose 116.22%, and September 2026 quarter net profit grew 60.62%. Long-term returns in promoter backed fast revenue growth and revenue CAGR stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.
Can Vijaya Diagnostic become a multibagger from here?
Ans. Vijaya Diagnostic has already gained 137.56% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in promoter backed fast revenue growth and revenue CAGR stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 11.81% a year since FY22, and FY26 revenue rose 19.34%. At a PE of 82.01 against an industry PE of 60.75, valuation should be checked against that growth before investing.
What is the market cap of Emmvee, Vijaya Diagnostic, Century Plyboards and TRIL?
Ans. As of 10 November 2026, Emmvee has a market cap of Rs 20,759 crore, Vijaya Diagnostic has a market cap of Rs 15,373 crore, Century Plyboards has a market cap of Rs 14,523 crore and TRIL has a market cap of Rs 9,221 crore. All of them qualify as smallcaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on promoter backed fast revenue growth and revenue CAGR stocks.
What are the risks of investing in promoter backed fast revenue growth and revenue CAGR stocks?
Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Vijaya Diagnostic trades at a PE of 82.01 against an industry PE of 60.75, so earnings growth needs to hold up.
Why is Vijaya Diagnostic trading at a PE of 82.01?
Ans. Vijaya Diagnostic’s PE of 82.01 compares with an industry PE of 60.75. The market is paying a premium for a return on equity of 18.07%, profit growth of 11.81% a year since FY22 and latest-quarter profit growth of 37.60%, which also means the stock is more sensitive if growth slows. Investors in promoter backed fast revenue growth and revenue CAGR stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.
How much do institutions hold in Emmvee, Vijaya Diagnostic, Century Plyboards and TRIL?
Ans. As of the latest reported quarter, FII and DII together hold 12.72% of Emmvee (2.92% and 9.80%), 43.16% of Vijaya Diagnostic (10.66% and 32.50%), 23.10% of Century Plyboards (3.61% and 19.49%) and 8.18% of TRIL (6.99% and 1.19%). Rising institutional holding is a useful signal in promoter backed fast revenue growth and revenue CAGR stocks, though it should be read with earnings trends rather than on its own.
